Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer

被引:240
作者
Ayoub, MA
Couturier, C
Lucas-Meunier, E
Angers, S
Fossier, P
Bouvier, M
Jockers, R
机构
[1] Inst Cochin Genet Mol, Dept Cell Biol, CNRS, UMR 8104,INSERM,U567, F-75014 Paris, France
[2] CNRS, UPR 9040, Neurobiol Cellulaire & Mol Lab, F-91198 Gif Sur Yvette, France
[3] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada
关键词
D O I
10.1074/jbc.M200729200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several G protein-coupled receptors have been shown to exist as homo-and hetero-oligomeric complexes in living cells. However, the link between ligand-induced receptor activation and its oligomerization state as well as the proportion of the total receptor population that can engage in oligomeric complexes remain open questions. Here, the closely related human MT1 and MT2 melatonin receptors (MT1R, MT2R) were used to address these issues. Bioluminescence resonance energy transfer (BRET) experiments in living HEK 293 cells revealed that these receptors form homo- and hetero-oligomers. Constitutive energy transfer was observed for all receptor combinations at physiological expression levels and could be detected in single cell BRET experiments. Inhibition of the energy transfer by dilution of the BRET partners identified MT1R and MT2R dimers as the predominant receptor species, and this oligomerization state did not change upon agonist and antagonist binding. Agonists, neutral antagonists, and inverse agonists all promoted increases in BRET values for MT2R but not for MT1R homodimers in living cells and isolated plasma membranes. This indicates that no correlation could be inferred between the receptor activation state and the dimerization state of the receptor. This also suggests that ligand-promoted BRET increases represent specific ligand-induced conformational changes of pre-existing dimers rather then increased dimerization. The observation that ligands favored the energy transfer within the hetero-oligomer from MT1R to MT2R but not in the reverse orientation, from MT2R to MT1R, supports this view.
引用
收藏
页码:21522 / 21528
页数:7
相关论文
共 36 条
[1]   Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) [J].
Angers, S ;
Salahpour, A ;
Joly, E ;
Hilairet, S ;
Chelsky, D ;
Dennis, M ;
Bouvier, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3684-3689
[2]   Dopamine D2 receptor dimer formation -: Evidence from ligand binding [J].
Armstrong, D ;
Strange, PG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) :22621-22629
[3]   Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32 [J].
Benkirane, M ;
Jin, DY ;
Chun, RF ;
Koup, RA ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30603-30606
[4]  
Boute N, 2001, MOL PHARMACOL, V60, P640
[5]   Oligomerization of G-protein-coupled transmitter receptors [J].
Bouvier, M .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (04) :274-286
[6]   Dual signaling of human Mel1a melatonin receptors via Gi2, Gi3, and Gq/11 proteins [J].
Brydon, L ;
Roka, F ;
Petit, L ;
de Coppet, P ;
Tissot, M ;
Barrett, P ;
Morgan, PJ ;
Nanoff, C ;
Strosberg, AD ;
Jockers, R .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (12) :2025-2038
[7]   Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer [J].
Cheng, ZJ ;
Miller, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (51) :48040-48047
[8]   Gonadotropin-releasing hormone receptor microaggregation -: Rate monitored by fluorescence resonance energy transfer [J].
Cornea, A ;
Janovick, DA ;
Maya-Núñez, G ;
Conn, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (03) :2153-2158
[9]   MELATONIN IS A POTENT MODULATOR OF DOPAMINE RELEASE IN THE RETINA [J].
DUBOCOVICH, ML .
NATURE, 1983, 306 (5945) :782-784
[10]   Melatonin receptor antagonists that differentiate between the human Mel(1a), and Mel(1b) recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML(1) presynaptic heteroreceptor [J].
Dubocovich, ML ;
Masana, MI ;
Iacob, S ;
Sauri, DM .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (03) :365-375